Internal Medicine, Nephrology · San Antonio, TX
NPI
1942436522
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
12011 State Highway 151 Ste 202
San Antonio, TX, 78251
Phone (210) 265-8155
Groups this clinician bills Medicare through
Medicare paid, 2024
$200K
2,373 services
Medicare patients, 2024
605
Average age 75
Drug cost, 2024
$941K
2,143 prescriptions
Company payments, 2025
$1,247
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saqib Z Syed was code 99233 (hospital e&m - subsequent), 614 times for 205 patients. In total Saqib Z Syed billed 2,373 services in 27 codes, and Medicare paid $200K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 614 | 205 | $89.38 | $55K |
| 99214 Office E&M - Established | Office | 493 | 243 | $63.83 | $31K |
| 99232 Hospital E&M - Subsequent | Facility | 336 | 164 | $59.61 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 183 | 137 | $12.34 | $2,259 |
| 99223 Hospital E&M - Initial | Facility | 148 | 137 | $126.54 | $19K |
| 90960 ESRD Related Services (not dialysis) | Office | 101 | 30 | $260.55 | $26K |
| 90935 Hemodialysis | Facility | 78 | 43 | $52.40 | $4,087 |
| 99291 Critical Care E&M | Facility | 52 | 25 | $157.88 | $8,210 |
| 90961 ESRD Related Services (not dialysis) | Office | 50 | 29 | $218.38 | $11K |
| 99222 Hospital E&M - Initial | Facility | 47 | 47 | $97.08 | $4,563 |
| 99204 Office E&M - New | Office | 32 | 32 | $122.75 | $3,928 |
| 99443 Telephone Services | Office | 31 | 25 | $60.04 | $1,861 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 19 | 19 | $68.31 | $1,298 |
By year: 2022 $224K for 2,414 services; 2023 $218K for 2,426 services; 2024 $200K for 2,373 services.
Medicare prescription drug claims, 2024
In 2024, the drug Saqib Z Syed prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 270 prescriptions and refills. In total Saqib Z Syed wrote 2,143 Medicare prescriptions that cost $941K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 270 | 487 | 64 | $269K |
| Furosemide Generic | 166 | 442 | 58 | $877 |
| Amlodipine Besylate Generic | 135 | 359 | 43 | $895 |
| Rayaldee Calcifediol | 131 | 137 | 23 | $189K |
| Jardiance Empagliflozin | 113 | 185 | 40 | $100K |
| Losartan Potassium Generic | 102 | 293 | 37 | $704 |
| Nifedipine Er Nifedipine | 85 | 239 | 32 | $2,383 |
| Hydralazine Hcl Generic | 80 | 221 | 43 | $878 |
| Carvedilol Generic | 59 | 168 | 20 | $460 |
| Lisinopril Generic | 57 | 155 | 27 | $360 |
| Calcitriol Generic | 53 | 139 | 16 | $1,178 |
| Allopurinol Generic | 48 | 142 | 18 | $318 |
| Kerendia Finerenone | 47 | 71 | 12 | $43K |
| Bumetanide Generic | 43 | 102 | 18 | $1,086 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 39 | 105 | 16 | $211 |
Brand drugs: - claims; generic drugs: 1,392 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saqib Z Syed $1,247 ($1,247 in general payments such as food, travel and fees) from 17 companies. The largest payer was Corcept Therapeutics with $233.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 2 | $233 |
| Amgen Inc. AMGN | 7 | $209 |
| Travere Therapeutics, Inc. TVTX | 2 | $147 |
| OPKO Pharmaceuticals, LLC | 20 | $144 |
| Novo Nordisk Inc NVO | 4 | $109 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $81.05 |
| Calliditas Therapeutics US Inc. | 3 | $73.68 |
| Akebia Therapeutics Inc AKBA | 2 | $42.3 |
| Mallinckrodt Hospital Products Inc. | 2 | $34.64 |
| Shield Therapeutics Inc STX.L | 2 | $31.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.